SCHEMBL7499580

SCHEMBL7499580

CCOC(=O)Cc1nc(-c2ccccc2)c(-c2ccc(S(N)(=O)=O)cc2)o1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 8/20 0.55
NR4A1 P22736 3/20 0.54
NR4A3 Q92570 3/20 0.54
KDM4E B2RXH2 2/20 0.49
HPGD P15428 2/20 0.49
ALDH1A1 P00352 1/20 0.49
RXRA P19793 4/20 0.49
RXRB P28702 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PTGS2 P35354 5/20 0.48
PTGS1 P23219 2/20 0.48
CA12 O43570 2/20 0.48
CA9 Q16790 2/20 0.48
KMT2A Q03164 1/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
ABCC4 O15439 1/20 0.46
C5 P01031 1/20 0.46
LMNA P02545 1/20 0.46
CHRM2 P08172 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7501262 1.00 NR4A2 (0.55) NR4A2NR4A1NR4A3KDM4EHPGD
SCHEMBL7506875 0.91 PTGS2 (0.61) NR4A2PTGS2PTGS1CA9KMT2A
SCHEMBL7503163 0.90 PTGS2 (0.60) NR4A2NR4A1NR4A3KDM4EHPGD
SCHEMBL7501153 0.90 PTGS2 (0.60) NR4A2NR4A1NR4A3KDM4EHPGD
SCHEMBL7506843 0.90 KDM4E (0.62) NR4A2NR4A1NR4A3KDM4EHPGD
SCHEMBL7506747 0.90 KDM4E (0.62) NR4A2NR4A1NR4A3KDM4EHPGD
SCHEMBL7505344 0.89 NR4A2 (0.56) NR4A2NR4A1NR4A3KDM4EHPGD
SCHEMBL5823418 0.89 NR4A2 (0.56) NR4A2NR4A1NR4A3KDM4EHPGD
SCHEMBL8557768 0.89 NR4A2 (0.68) NR4A2NR4A1NR4A3KDM4EHPGD
SCHEMBL7502572 0.88 RXRA (0.57) NR4A2NR4A1NR4A3KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 EP claimed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 EP claimed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 WO claimed
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 EP disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 WO disclosed